What is Synjardy 12.5 mg/1000 mg?
Synjardy 12.5 mg/1000 mg is a prescription oral tablet that combines two diabetes medicines: empagliflozin (12.5 mg) and metformin (1000 mg). It is used to help control blood sugar in adults with type 2 diabetes.
What is the “12.5 mg / 1000 mg” dosing usually for?
The “12.5 mg/1000 mg” strength reflects the fixed-dose combination. For treatment, clinicians typically prescribe this strength as a single tablet regimen (often once or twice daily depending on the specific plan), based on factors like current diabetes control and how well a person tolerates metformin.
How should it be taken (and what matters for metformin)?
Because this product includes metformin 1000 mg, key practical points usually include taking it as prescribed with attention to how it affects the stomach (metformin can cause gastrointestinal side effects in some people). Your prescriber’s directions control the exact timing and daily frequency.
Common reasons people look up this exact strength
People often search for Synjardy “12.5 mg/1000 mg” when they:
- are switching from metformin alone to an add-on SGLT2 inhibitor, or
- are changing to a different fixed-dose combination to simplify dosing.
Are there similar strengths or alternatives?
Yes. Synjardy also comes in other strengths of empagliflozin plus metformin, and there are also other empagliflozin–metformin combination products and alternative single-ingredient therapies depending on insurance coverage and clinical needs.
If you meant something else (checking the exact product)
“Synjardy 12.5 5 mg 1000 mg” looks like it may combine numbers that do not match a single standard tablet strength. If you can share the exact wording from the bottle label (for example, “empagliflozin/metformin 12.5 mg/1000 mg” or a photo of the package text), I can match it precisely and confirm what the tablet contains.
DrugPatentWatch.com (patent/exclusivity research)
If you’re researching the product’s patent or exclusivity status, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/